Word mark

Oy Juvantia Pharma Ltd.
European Community Trademark, no. 001039312, Word mark


On 11. 1. 1999 the community trademark application no. 001039312 was filed for TARGETED HIGH-THROUGHPUT DRUG DISCOVERY (Word mark) by Oy Juvantia Pharma Ltd. before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 1, 5 and 42. The current status of the trademark is application refused.

Status is 'Application refused'
The Community Trade Mark application has been rejected during the registration phase. The refusal may be based on formalities, classification, absolute grounds or relative grounds, i.e. as a result of an opposition.

Applied11. 1. 1999
Nice classes1, 5, 42


You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.



Oy Juvantia Pharma Ltd.
Tykistökatu 6 A
20520 Turku


If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89


Berggren Oy, Turku
Tykistökatu 2-4 B
20520 Turku


If the data above is not correct, then please choose Update.


Nice classes

1  Chemical preparations for scientific purposes, especially libraries of chemical compounds; chemical reagents; chemical substances and preparations for use in analyses in laboratories; biological preparations.

5  Therapeutically active agents, particularly libraries of therapeutically active chemical compounds; pharmaceutical preparations; veterinary preparations; diagnostic preparations for medical or veterinary purposes; biological preparations for medical or veterinary purposes.

42  Scientific and industrial research, particularly research relating to pharmaceuticals and receptor studies; chemical analysis and research, particularly pharmaceutical screening assays and other bioaffinity assays; pre-synthetic drug design, molecule modelling; chemical synthesis, particularly in the field of combinatorial chemistry.


Further trademarks of the owner